Related Experiment Video
Updated: Jan 22, 2026

Orthotopic Mouse Model of Colorectal Cancer
Published on: December 4, 2007
Melatonin: An important anticancer agent in colorectal cancer
Mohammad Mirza-Aghazadeh-Attari1,2, Amir Mohammadzadeh1,2, Soroush Mostavafi1,2
1Student Research Committee, Tabriz University of Medical Sciences, Tabriz, Iran.
Abstract:
Colorectal cancer is one of the most common cancers among the elderly, which is also seen in the forms of hereditary syndromes occurring in younger individuals. Numerous studies have been conducted to understand the molecular and cellular pathobiology underlying colorectal cancer. These studies have found that cellular signaling pathways are at the core of colorectal cancer pathology. Because of this, new agents have been proposed as possible candidates to accompany routine therapy regimens. One of these agents is melatonin, a neuro-hormone known best for its essential role in upholding the circadian rhythm and orchestrating the many physiologic changes it accompanies. Melatonin is shown to be able to modulate many signaling pathways involved in many essential cell functions, which if deregulated cause an accelerated pace towards cancer. More so, melatonin is involved in the regulation of immune function, tumor microenvironment, and acts as an antioxidant agent. Many studies have focused on the beneficial effects of melatonin in colorectal cancers, such as induction of apoptosis, increased sensitivity to chemotherapy agents and radiotherapy, limiting cellular proliferation, migration, and invasion. The present review aims to illustrate the known significance of melatonin in colorectal cancer and to address possible clinical use.
Insights
Melatonin, a circadian rhythm hormone, shows promise in colorectal cancer treatment by regulating cell signaling pathways. This review explores its potential role in enhancing conventional therapies and its anticancer effects.
Area of Science:
- Oncology
- Molecular Biology
- Endocrinology
Background:
- Colorectal cancer (CRC) is a prevalent malignancy, particularly in the elderly, but also occurs in younger individuals via hereditary syndromes.
- Dysregulated cellular signaling pathways are central to CRC pathology.
- Melatonin, a neuro-hormone crucial for circadian rhythm, modulates various signaling pathways.
Purpose of the Study:
- To review the significance of melatonin in colorectal cancer.
- To explore the potential clinical applications of melatonin in CRC treatment.
Main Methods:
- Literature review of studies on melatonin and colorectal cancer.
- Analysis of melatonin's effects on cellular signaling, immune function, and tumor microenvironment.
- Examination of melatonin's role in apoptosis, proliferation, migration, and invasion.
Main Results:
- Melatonin modulates key signaling pathways implicated in CRC.
- It exhibits antioxidant properties and influences the tumor microenvironment and immune function.
- Studies indicate melatonin can induce apoptosis, enhance sensitivity to chemotherapy and radiotherapy, and inhibit cancer cell proliferation, migration, and invasion.
Conclusions:
- Melatonin demonstrates significant potential as an adjuvant therapy for colorectal cancer.
- Further clinical research is warranted to establish its therapeutic efficacy and optimal use in CRC management.
Related Concept Videos
Subviral Agents
Air-entraining Agents
Masking and Demasking Agents
There are many masking agents, such as cyanide, fluoride, triethanolamine, thiourea, and 2,3-bis(sulfanyl)propan-1-ol (formerly 2,3-dimercapto-1-propanol), with the masking agent chosen based on...
Oral Hypoglycemic Agents: Glinides
Spasmolytic Agents: Chemical Classification
A major class of centrally acting spasmolytics is the α2-agonist, such as tizanidine. These drugs bind to α2-adrenoceptors, inhibiting the release of the excitatory neurotransmitter glutamate. They also...
Chemical Agents for Microbial Control

